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Dear Dr. Nash, 
 
I liked your article in the Health Policy Newsletter about the Leapfrog group. I 
couldn’t agree more that we’ve focused too much on cost containment and too little 
on quality. I also agree that it is important for purchasers to select and reward plans 
and providers based on quality of care. I think this is obvious to people when they 
buy cars (e.g., everyone looks in the consumer reports ratings), but not health care. 
 
There is one aspect that makes this “market strategy” difficult. Purchasers usually 
select insurance plans for their beneficiaries, and pay the plans for the services. 
Therefore, purchasers may be able to leverage plans to improve quality. The problem 
is that health plans do not provide quality care (or poor quality care). Rather, 
physicians and other health professionals do. 
 
Therefore, in order to change behavior, it is the physicians that have to be selected 
and rewarded based on their performance. When there is a clear distinction between 
plans because of different provider panels, I can see how this would work: health 
plans would pay physicians for higher quality care, and purchasers would pay the 
plans more when their physicians perform better. However, in markets like ours (i.e., 
Delaware), where almost all physicians participate in almost all health plans, that 
may not work. That’s because physicians participate in many different plans. So 
having Aetna reward him for increased rates of cholesterol screening means very 
little when it is only 5-10 of his patients. Even if Aetna’s reward does succeed in 
improving rates, it will likely translate into better rates across all of his patients. 
Therefore Aetna could be paying for higher quality, but it really leads to higher 
quality across all plans. So Aetna does not gain any competitive advantage, and has 
little incentive to continue to pay for this higher quality. 
 
James M. Gill, MD, MPH 
Director, Health Services Research 
Department of Family and Community Medicine 
Christiana Care Health System 
 
* * * * *
Dear Dr. Nash, 
 
Thanks for your interesting article. I read it, thought about it, and visited the 
Leapfrog Web site. I think it’s interesting that the group seems to focus on patient 
safety. Clearly this is a critical issue. But I’d focus more on the quality or value 
aspects of purchased healthcare. 
 
Here the big purchasers could circumvent the MCOs. I believe NCQAdoes a modest 
job of focusing plans on quality, but I’m struck by the high percentage of energy 
spent on writing good compliance statements, having good meeting minutes, and 
other window-dressing. And NCQA’s interrater reliability problems are legendary. 
Worse, I know that perfectly average plans get commendable ratings. 
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I believe big-business purchasers could do a lot to improve quality, safety, and 
value- and I hope they do it. The Leapfrog Group has some good ideas. My guess is 
it will take people who understand healthcare and can avoid the special interests of 
providers, health plans, and company budgets while they build employee demand for 
value. 
 
Anthony Heath, PhD 
 
* * * * *
Dear Dr. Nash, 
 
Your editorial in the December 2000 issue about the concept of leapfrogging and the 
Leapfrog Group resonated with my concerns. Some recent attempts to cooperate 
with managed care organizations, to improve the outcomes of drug therapy, had 
suggested to me that they were really unable to manage care, merely the cost of 
care. The logical next step would be an appeal to their customers, the real players. 
 
Prof. Charles D. Hepler 
College of Pharmacy, University of Florida 
Director, DuBow Family Center for Research in Pharmaceutical Care 
 
* * * * *
Dear Dr. Nash, 
 
I always enjoy seeing the Health Policy Newsletter and in the December 2000 issue I 
especially appreciated the Leapfrogging Quality editorial. Quality is a most important 
topic, and I am very pleased to see employers take a pro-active approach in pushing 
quality concerns. Please continue with the informative and well-written editorial 
pieces. 
 
Will Wright, MD 
Medical Director 
Med Michigan Health Network 
 
* * * * *
Dear Dr. Nash: 
 
I read with great interest your editorial on "Leapfrogging Quality" published in the 
December issue of the Jefferson Health Policy Newsletter. I have been fascinated and 
frustrated by the desperately slow pace of technological innovation and adaptation of 
the medical "business". I have also been impressed with your leadership in the area 
of study of medical utilization and efficiency. 
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As a family physician and medical director of a primary care practice in Pottstown, PA 
I have significant operational responsibilities. The practice is owned by a hospital 
system. The operational inefficiency I have encountered here and in previous 
practice experience is the result of internal as well as external factors. Whatever the 
cause of the waste, it is unconscionable to me that we continue to tolerate it at a 
time when hospitals, medical practices and insurance companies are all financially 
suffering. Even more frustrating is the extent to which the inefficiency of the system 
creates a burden on some of our most needy citizens. The high cost of medications 
and insurance to a large portion of our population restricts their access to and quality 
of care. 
 
The effort to take a “leap” forward and to concentrate great minds and leaders 
(which are not necessarily mutually exclusive) to the task of bringing medicine into 
the 21st century is critically important. This effort has the potential to be a 
watershed event in the evolution of medical care delivery in the U.S. Best of luck in 
this courageous effort. 
 
Charles L Buttz, MD, MBA 
Medical Director 
Coventry Family Care 
Pottstown PA 
 
* * * * *
Please note: the comments expressed by the authors in this publication do 
not necessarily represent the views of the Editorial Board, Thomas Jefferson 
University, Jefferson Medical College, Jefferson Health System  
or the Office of Health Policy and Clinical Outcomes. 
